Loading…
Hosted by Nusano · 🇺🇸 US · EN · 12 episodes
Established thought leaders with verified media credentials.
Radioisotopes are revolutionizing how cancers are detected and treated. But how do they work? And where is this field headed? Whether you’re a healthcare professional, researcher, pharma exec, or industry analyst, this podcast is a go-to resource for the rapidly evolving radiopharmaceuticals landscape.Welcome to Talk Radioisotopes: Going Nuclear on Cancer. We’ll take a look at the latest insights, trends and developments working to change patient outcomes and supply the fight against cancer. Join host Scott Larrivee and experts from across the industry, as they break down the science, shed light on real-world opportunities, and take a peek behind the curtain at the people, companies, and programs driving innovation in nuclear medicine. This is Talk Radioisotopes: Going Nuclear on Cancer.Brought to you by the team at Nusano.
Nusano hosts Talk Radioisotopes: Going Nuclear on Cancer, a health show with 12 episodes published.
In this episode of Talk Radioisotopes, Paul Schrimpf, Proprietor and Entrepreneur at Cyrall, unpacks what it takes to build and scale a radiopharmaceutical business. With a background spanning Accenture, Prophet, and lea
In this episode of Talk Radioisotopes, host Scott Ravi sits down with Sigal Kalmanson Cusnir, CEO and Co-Founder of Starget Pharma, an early-stage company at the forefront of precision oncology. Starget is redefining the
In this episode, Milton Lönnroth, Co-Founder and CEO, shares how Atley Solutions is changing the game for astatine-211, a promising isotope in cancer therapy. Atley supports radiopharmaceutical companies and researchers
In this episode, host Scott Larrivee speaks with Dr. Luke Nordquist, a medical oncologist and Founder/CEO of XCancer, a globally recognized clinical research center. Dr. Nordquist shares the origin story of XCancer—born
On this episode, hosts Scott and Sarah are joined by Matt Furlow, Associate Principal at ZS, about the evolving role of radiopharmaceuticals in oncology. With a PhD in bioengineering and a decade of consulting experience
On this episode, hosts Scott and Sarah sit down with Dr. Suzanne Lapi, Professor of Radiology and Chemistry and Cyclotron Facility Director at the University of Alabama at Birmingham. The conversation dives into Dr. Lapi
On this episode of Talk Radioisotopes, Scott and Sarah are joined by Dr. Shamar Young, Chief Medical Officer at TeleDaaS and Division Chief of Interventional Radiology at the University of Arizona. The discussion explore
In this episode of Talk Radioisotopes, hosts Scott and Sarah welcome Bruno Paquin, CEO of AtomVie Global Radiopharma. Bruno delves into the complexities and advancements of the radiopharmaceutical industry. The discussio
On this episode of Talk Radioisotopes, hosts Scott Larrivee and Sarah Scouten interview Arjun Murthy, co-founder of Maven Bio, an AI-driven biopharma market intelligence platform. They explore how Arjun's background, alo
On this episode, hosts Scott and Sarah sit down with Shaemus Gleason, Executive Vice President at Clarity Pharmaceuticals. The discussion highlights Shaemus's journey through the radiopharmaceutical industry, Clarity's i
On our first episode of ‘Talk Radioisotopes: Going Nuclear on Cancer,' host Scott Larrivee is joined by co-host Dr. Sarah Scouten and guest Jeff Jones of Oppenheimer & Company. The discussion covers the latest trends in
Radioisotopes are revolutionizing how cancers are detected and treated. But how do they work? And where is this field headed? Whether you’re a healthcare professional, researcher, pharma exec, or industry analyst, this p
Sponsor detection runs nightly. Check back soon.
No public pitch examples yet for this show.
Generate your own personalised pitchBased on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:
Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
Talk Radioisotopes: Going Nuclear on Cancer has a verified contact on file. Create a free PitchCentric account to access it and generate a personalised pitch in seconds. Research at least 3 recent episodes first and lead with a specific angle that serves their health audience.
Talk Radioisotopes: Going Nuclear on Cancer is hosted by Nusano. The show is categorised under health (fitness) and has published 12 episodes.
Talk Radioisotopes: Going Nuclear on Cancer has published 12 episodes.
Talk Radioisotopes: Going Nuclear on Cancer regularly covers health, fitness, technology. It sits in the health category, with a fitness focus.
Talk Radioisotopes: Going Nuclear on Cancer is accessible for guests with genuine health expertise. A personalised, episode-aware pitch will still outperform a generic one every time.
Talk Radioisotopes: Going Nuclear on Cancer hasn't explicitly signalled guest openness in recent episodes. That doesn't rule out pitching. your hook just needs to be especially compelling and relevant to their recent content.
Episodes of Talk Radioisotopes: Going Nuclear on Cancer average 32 minutes. a focused format where a clear narrative arc and tight preparation matter most.
Our data rates Talk Radioisotopes: Going Nuclear on Cancer's guest bar at 80/100 (Premium tier). Established thought leaders with verified media credentials. Sign in to PitchCentric to see how your own Pod Score compares against this show.
Methodology. Booking Probability™ blends Listen Score, 30-day Virality, open-to-guests detection, and Apple ratings. Data refreshed every 60 minutes. Listen Score and Booking Probability are calculated by PitchCentric. Last enriched yesterday.